Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis
AI Summary
Most inflammatory markers did not distinguish negative symptom subtypes at UHR, though higher sICAM-1 associated with lower odds of primary negative symptoms.
Younger age increased odds of primary negative symptoms and amotivation, while smoking increased odds of secondary negative symptoms compared with no negative symptoms.
Study limited by sample ascertainment, potential negative symptom misclassification and small PNS numbers; larger longitudinal studies required to clarify inflammatory contributions.
Early Interv Psychiatry. 2026 Jul;20(7):e70183. doi: 10.1111/eip.70183.
ABSTRACT
AIMS: Negative symptoms are a core component of schizophrenia, affecting up to 60% of individuals with the disorder. They are categorised into primary negative symptoms (PNS), which are intrinsic to the illness, and secondary negative symptoms, which arise from external factors such as depression or medication side effects. They can also be divided into diminished expression and amotivation/anhedonia subtypes. While inflammation has been implicated in schizophrenia and linked to negative symptoms, little is known about whether inflammatory profiles differ between negative symptom subtypes in individuals at Ultra-High Risk (UHR) for psychosis.
METHODS: We conducted a secondary analysis of 147 UHR participants from the Staged Treatment in Early Psychosis (STEP) study to examine whether inflammatory markers (Alpha-2-Macroglobulin, IL-6, CRP, sICAM-1, sVCAM-1, and suPAR) differed across negative symptom subgroups, using multinomial and binomial logistic regression models adjusted for age, sex, smoking, and BMI.
RESULTS: Overall, most inflammatory markers were not significantly associated with negative symptom subgroups. However, higher sICAM-1 levels were asscoiated with lower odds of primary negative symptoms compared with no negative symptoms. Additionally, younger age was associated with increased odds of PNS and amotivation, while smoking was associated with higher odds of secondary negative symptoms compared with no negative symptoms.
DISCUSSION: These findings suggest that inflammation may not broadly distinguish negative symptom subtypes at the UHR stage, although sICAM-1 may play a role in early illness processes. Limitations include sample ascertainment, potential misclassification of negative symptoms, and the relatively small number of participants with PNS. Future studies with larger samples and longitudinal designs are needed to clarify whether inflammatory changes contribute to the emergence of specific negative symptom subtypes.
Clin Psychol Psychother. 2026 Jul-Aug;33(4):e70304. doi: 10.1002/cpp.70304.ABSTRACTThis study examined the role of perceived stress in intervention-related change during a mindfulness-based intervention (MBI) for emotional distress...
JAMA Netw Open. 2026 Jul 1;9(7):e2620687. doi: 10.1001/jamanetworkopen.2026.20687.ABSTRACTIMPORTANCE: Cognitive impairment is common in long COVID and severely affects daily life, with no proven treatments to...
JAMA Psychiatry. 2026 Jul 1. doi: 10.1001/jamapsychiatry.2026.1752. Online ahead of print.ABSTRACTIMPORTANCE: Peer networks may influence early psychiatric vulnerability, both through direct exposure to peers' mental...
